CARE Act Cold-blooded Animal Research and Exhibition Act
Impact
Should HB9571 be enacted, it would necessitate a revision of existing policies and regulations concerning the use of cold-blooded animals in laboratory research, exhibitions, and as pets. This change would require institutions involved in such activities to adopt more stringent care practices and protocols to ensure the welfare of these species. By formally recognizing cold-blooded animals as protected under the Animal Welfare Act, the legislation signifies a notable progress in animal rights advocacy, reflecting growing public concern regarding the treatment of diverse species in captivity and research settings.
Summary
House Bill 9571, also known as the Cold-blooded Animal Research and Exhibition Act (CARE Act), aims to amend the Animal Welfare Act to categorize cold-blooded species, including reptiles, amphibians, cephalopods, and fish, as animals deserving of legal protection and consideration under the Act. This bill represents a significant shift in how animal welfare is approached, embracing a wider range of species beyond just warm-blooded animals traditionally protected under U.S. law. By expanding the definition of 'animal' to incorporate these cold-blooded species, HB9571 seeks to enhance the ethical treatment of all animals involved in research and exhibition scenarios.
Contention
Despite its potential positive impacts, the bill is likely to encounter opposition from various stakeholders in sectors such as biomedical research and aquaculture, who may argue that the imposition of additional regulations would complicate or hinder essential work with these species. Some opponents may also express concerns about the economic implications for industries that utilize cold-blooded animals for research and education purposes, highlighting the need for a balanced approach that accounts for both animal welfare and scientific advancement.